Manefield et al., 2003 - Google Patents
Controlling bacterial infection by inhibiting intercellular signallingManefield et al., 2003
- Document ID
- 20060787334603654
- Author
- Manefield M
- Kjelleberg S
- Givskov M
- Publication year
- Publication venue
- Current Medicinal Chemistry-Anti-Infective Agents
External Links
Snippet
The opportunistic human pathogen Pseudomonas aeruginosa, which causes fatal lung infections in cystic fibrosis patients, regulates the expression of virulence factors by N-acyl- Lhomoserine lactone (AHL) mediated gene expression. AHL mediated gene expression …
- 230000002401 inhibitory effect 0 title abstract description 13
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/06—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LaSarre et al. | Exploiting quorum sensing to confuse bacterial pathogens | |
| Hentzer et al. | Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections | |
| Grandclément et al. | Quorum quenching: role in nature and applied developments | |
| McDougald et al. | Bacterial quorum sensing and interference by naturally occurring biomimics | |
| Rasmussen et al. | Quorum-sensing inhibitors as anti-pathogenic drugs | |
| Kalia et al. | Evolution of resistance to quorum-sensing inhibitors | |
| Rampioni et al. | The art of antibacterial warfare: deception through interference with quorum sensing–mediated communication | |
| Williams | Quorum sensing: an emerging target for antibacterial chemotherapy? | |
| Dobretsov et al. | Mini-review: quorum sensing in the marine environment and its relationship to biofouling | |
| Defoirdt et al. | Disruption of bacterial quorum sensing: an unexplored strategy to fight infections in aquaculture | |
| Raffa et al. | Bacterial communication (“quorum sensing”) via ligands and receptors: a novel pharmacologic target for the design of antibiotic drugs | |
| Musk Jr et al. | Chemical countermeasures for the control of bacterial biofilms: effective compounds and promising targets | |
| Zhang et al. | Quorum sensing and signal interference: diverse implications | |
| Pan et al. | Quorum sensing inhibitors: a patent overview | |
| You et al. | Inhibition of Vibrio biofilm formation by a marine actinomycete strain A66 | |
| Lowery et al. | Interspecies and interkingdom communication mediated by bacterial quorum sensing | |
| Roy et al. | Developing next generation antimicrobials by intercepting AI-2 mediated quorum sensing | |
| Rasmussen et al. | Quorum sensing inhibitors: a bargain of effects | |
| Singh et al. | Lagerstroemia speciosa fruit extract modulates quorum sensing-controlled virulence factor production and biofilm formation in Pseudomonas aeruginosa | |
| Lowery et al. | Medicinal chemistry as a conduit for the modulation of quorum sensing | |
| Subhadra et al. | Quorum sensing in Acinetobacter: with special emphasis on antibiotic resistance, biofilm formation and quorum quenching | |
| Li et al. | The role of bacterial signaling networks in antibiotics response and resistance regulation | |
| Choi et al. | Inhibitory effects of 4-hydroxy-2, 5-dimethyl-3 (2H)-furanone (HDMF) on acyl-homoserine lactone-mediated virulence factor production and biofilm formation in Pseudomonas aeruginosa PAO1 | |
| Nag et al. | Quorum sensing | |
| Khmel | Quorum-sensing regulation of gene expression: fundamental and applied aspects and the role in bacterial communication |